AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Simezan Tablet SR

Prescription Icon
Prescription Required

Marketer

Zaney Pharma Private Limited

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Simezan Tablet SR

Diabexe SR tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action mitigates severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risks. Diabexe SR may be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concurrent medications. Consuming Diabexe SR with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Continued commitment to the prescribed diet and exercise plan is crucial for successful diabetes management. Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when used with insulin or sulfonylureas; patients should learn hypoglycemia recognition and management. Diabexe SR is not universally suitable. Prior to initiating treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women require medical consultation before use. Inform your doctor of all medications you are taking to avoid potential drug interactions. Alcohol should be avoided due to its hypoglycemic effects. Your physician will monitor renal function and blood glucose levels throughout the treatment course.

Primary Ingredients of Simezan Tablet SR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Simezan Tablet SR

Managing type 2 diabetes

Major Benefits of Simezan Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Simezan SR tablet whole; do not chew, crush, or divide it. Administer this medication with food.

Common Side effects of Simezan Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Simezan Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Simezan SR Tablet with food.

How Simezan Tablet SR works:

Simezan SR tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Simezan Tablet SR and alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Simezan Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Simezan tablets pose a likely risk during lactation. Available human data indicate potential drug transfer via breast milk, potentially harming the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Simezan SR tablets, potentially requiring dosage modification. Severe kidney disease contraindicates Simezan SR tablet use. Consult your physician. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The use of Simezan Tablet SR is potentially hazardous for individuals with hepatic impairment and is best avoided. Seek medical advice.

What if you forget to take Simezan Tablet SR :

Should you forget a Simezan Tablet SR dose, take it promptly. However, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Simezan Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Simezan Tablet SR

Simezan SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. Simezan SR is not suitable for individuals under 18.
Prolonged Simezan Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Simezan Tablet SR may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects such as lactic acidosis are possible. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Simezan Tablet SR components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Simezan SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Yes, Simezan Tablet SR (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Simezan Tablet SR combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Simezan Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Simezan Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Simezan Tablet SR and alcohol is unsafe and may heighten the risk of lactic acidosis.
Simezan Tablet SR can cause lactic acidosis (MALA), a serious medical emergency resulting from excess blood lactic acid. This rare side effect, more likely in patients with kidney disease, advanced age, or high alcohol consumption, necessitates avoidance in such individuals. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Simezan Tablet SR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Simezan SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Simezan Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Simezan Tablet SR is contraindicated in patients allergic to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Simezan SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Simezan Tablet SR. This condition, resulting from excessive blood lactic acid, is rare but more likely in individuals with kidney disease, the elderly, or those who consume significant alcohol. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms after taking Sitagliptin + Metformin, discontinue use and seek immediate medical attention.
Prolonged Simezan Tablet SR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Simezan Tablet SR
226